142个化药退市！ 来源：药渡 药物撤市三大原因，安全性问题、同类产品替代、�管政策变动；其中，安全性问题是药物撤市最为强制且无可奈何的原 Sketch Coloring Page

142个化药退市！ 来源：药渡 药物撤市三大原因，安全性问题、同类产品替代、�管政策变动；其中，安全性问题是药物撤市最为强制且无可奈何的原 Template

Background image: Hide Show

View Larger Image Image Credit: xueqiu.com

please wait, the page is loading...

More Sketches

Take a peek at some of the sketches created by our users, are you a sketchite?

sketch #4351

anonymous

anonymous
sketch #4351

sketch #3496

anonymous

anonymous
sketch #3496

sketch #1249

Laura Agapi Asnicar
sketch #1249

sketch #5350

anonymous

anonymous
sketch #5350

sketch #1477 123 viva l 'algerie

anonymous

anonymous
sketch #1477 123 viva l 'algerie

sketch #3425 &#;Tonari no Kaibutsu-kun&#; by Betty Marie Melzer

anonymous

anonymous
sketch #3425 &#;Tonari no Kaibutsu-kun&#; by Betty Marie Melzer

sketch #3695

Mahmed Alhaj
sketch #3695

sketch #5067

anonymous

anonymous
sketch #5067

sketch #5268 Harley Quinn by 조바다

anonymous

anonymous
sketch #5268 Harley Quinn by 조바다

sketch #1153 sahib

anonymous

anonymous
sketch #1153 sahib

sketch #2459 funky afro

sketchmaster
sketch #2459 funky afro

sketch #4298

anonymous

anonymous
sketch #4298

sketch #314 Butterfly

anonymous

anonymous
sketch #314 Butterfly

sketch #3974 Bird Skerch w/ vibration

anonymous

anonymous
sketch #3974 Bird Skerch w/ vibration

sketch #5287

anonymous

anonymous
sketch #5287

sketch #855

Laura Agapi Asnicar
sketch #855

sketch #5156 Angry Bird by Roberto Castro Colimil

anonymous

anonymous
sketch #5156 Angry Bird by Roberto Castro Colimil

sketch #3447 Hidan (Akatsuki) by ßeyza Karaca

anonymous

anonymous
sketch #3447 Hidan (Akatsuki) by ßeyza Karaca

sketch #5227

anonymous

anonymous
sketch #5227

sketch #5131 Miley Cyrus by Vannak Von

anonymous

anonymous
sketch #5131 Miley Cyrus by Vannak Von

sketch #2777 Ralph & Vanellope by Alexander Volodimirovich Danilchenko

Alexander Volodimirovich Danilchenko
sketch #2777 Ralph & Vanellope by Alexander Volodimirovich Danilchenko

sketch #4724 Turtwig by Mark Robson

anonymous

anonymous
sketch #4724 Turtwig by Mark Robson

sketch #1652

anonymous

anonymous
sketch #1652

sketch #878

Laura Agapi Asnicar
sketch #878

sketch #4882 Monsters University by John Davis

anonymous

anonymous
sketch #4882 Monsters University by John Davis

sketch #3448 Treba mi bolji

anonymous

anonymous
sketch #3448 Treba mi bolji "mish " ;)

sketch #3639

anonymous

anonymous
sketch #3639

sketch #4589

anonymous

anonymous
sketch #4589

sketch #5077 Light of Hope by Itz Rakhi

anonymous

anonymous
sketch #5077 Light of Hope by Itz Rakhi

sketch #2477 hhhh

anonymous

anonymous
sketch #2477 hhhh

tomski142个化药退市！ 来源：药渡 药物撤市三大原因，安全性问题、同类产品替代、�管政策变动；其中，安全性问题是药物撤市最为强制且无可奈何的原 coloring

142个化药退市！ 来源：药渡 药物撤市三大原因，安全性问题、同类产品替代、�管政策变动；其中，安全性问题是药物撤市最为强制且无可奈何的原 sketch template

142个化药退市！ 来源：药渡 药物撤市三大原因，安全性问题、同类产品替代、�管政策变动；其中，安全性问题是药物撤市最为强制且无可奈何的原 sketch template

90个药品撤�，其中38个中成药！中药国采在即，大批中药迎撤�潮 �熵医药原药融� sketch template

142个化药退市！ 来源：药渡 药物撤市三大原因，安全性问题、同类产品替代、�管政策变动；其中，安全性问题是药物撤市最为强制且无可奈何的原 sketch template

�伦药业再冲首仿！4类仿制化药布�哌�片上市申请获CDE受理 �熵医药原药融� sketch template

行业资讯年报：2023年生物医药产业运行报� 深圳市生物医药促进会 sketch template

142个化药退市！ 来源：药渡 药物撤市三大原因，安全性问题、同类产品替代、�管政策变动；其中，安全性问题是药物撤市最为强制且无可奈何的原 sketch template

万亿市场突围！GLP 1药物推动产业链�展，华东、信达产业链激动剂原料药注射笔信达药物华东突围推动万亿多肽靶点 sketch template

扬子江药业：4类仿制化药他氟前列素滴眼液获批并视同过评 �熵医药 sketch template

中药经典名方来袭，3款化药1类新药报产！恒�、信立泰、�花… 知乎 sketch template

产业大�年报：2023年生物医药产业运行报� 知乎 sketch template

宁波市生物医药产业�展简报2023年 药智新闻 sketch template

大涨75192%，打破竞争格局！6款国产口溶膜剂上市，齐鲁制药占5款！咱们书接上回！接着上篇文章《势头强劲，大涨21799%！25个化药 sketch template

10月生物医药产业运行报�：融资额环比上升超4成，新增企业10万家 sketch template

11月生物医药产业运行月报：新增企业13万家，融资事件数创新高 OFweek医疗�技� sketch template

厉害了！“抗癌药第一股”贝达药业、以岭药业新药获批临床！一款在研药物获得临床批件，意�着该药物经过了严格的临床试验和评估，并被证明具有 sketch template

12亿重磅品种、大涨818%注射剂！石家庄四药同日拿下仿制药过评 �日，石家庄四药集团�布公�，公司同时拿下2款仿制药过评批文，分别为12亿重 sketch template

中国二类新药�展现状及�展趋势 药智新闻 sketch template

规模每年新增100亿，临床试验数字化序幕开启数字化受试者规模临床企业健康界 sketch template

河南省生物医药产业�展解析知乎 sketch template

2024上半年，中美批准新药对比腾讯新闻 sketch template

新药加速度！51款新药获批临床，1款上市！用于治疗庞贝病患者艾夫糖苷酶庞贝病加速度数据库新药患者获批临床上市治疗药物 sketch template

100%预防艾滋！吉利德�学创新药物Lenacapavir 3期临床结果喜人 来源：药渡撰文：睿睿李艾滋病是由HIV病毒感染造成的传染性疾病 sketch template

142个化药退市！ 来源：药渡 药物撤市三大原因，安全性问题、同类产品替代、�管政策变动；其中，安全性问题是药物撤市最为强制且无可奈何的原 sketch template

2024上半年，中美批准新药对比腾讯新闻 sketch template

小核酸药体外研究案例分析知乎 sketch template

最有价值的10款在研新药之——潜在重磅化药专利面面观知乎 sketch template

如何利用药代力动学确定给药时间生物器材� sketch template

每日一药Ataluren/Translarna® 知乎 sketch template

解析Madrigal的THR β选择性激动剂Resmetirom的�现和优化 来源：药渡CyberResmetirom是一款肝脏甲状腺素受体β sketch template

药渡Cyber解析CCR6拮抗剂IDOR 1117 2520的�现 来源：药渡Cyber快看版免疫细胞迁移到炎症部位是身体对感染反应的关键步骤 sketch template

解析IRAK4�制剂BAY1834845和BAY1830839分子设计和优化详解 来源：药渡Cyber作为IL 1R信号通路中第一个激酶，白 sketch template

双抗之后，三特异性抗体药物受到关注目前全球已经有17款双特异抗体药物上市，并且已有�1000款双抗药物在研，涉及企业超400家，可以说双抗的 sketch template

药渡看靶点赛道系列02——FLT3靶点全球研�格局分析知乎 sketch template

药渡cyber解析阿斯利康开�的MCT4临床候选物AZD0095的设计思路知乎 sketch template

free web stats